ReBuilder Medical Technologies, Inc. Retains Premier Media Services to Assist with Investor and Public Relations; Established $4M Private Company Now Publicly Traded

    CHARLES TOWN, W.V., July 20 /PRNewswire-FirstCall/ -- ReBuilder Medical
 Technologies, Inc. (OTC Pink Sheets: RBRM),
 (http://www.rebuildermedical.com), manufacturer of patent-pending
 treatments for Neuropathy, Molluscum Contagiosum and Diabetes, today
 announced that it has retained Premier Media Services based in Phoenix,
 Arizona, to assist with its investor and public relations efforts.
     David B. Phillips, PhD, founder and President of ReBuilder Medical
 Technologies, Inc., said, "Our story is an excellent one and now that we
 have taken the company public, our achievements need broader exposure to
 potential investors and product buyers. Premier Media Services has an
 excellent track record in doing this work."
     "We look forward to increasing awareness of the important technologies
 and products produced by ReBuilder Medical," said Kelly Black, CEO of
 Premier Media Services. "We are impressed with the company's management
 team and business strategies."
     About ReBuilder Medical Technologies, Inc.:
     ReBuilder Medical Technologies, Inc. has been successfully inventing,
 developing, manufacturing and distributing medical devices for five years
 via the internet. Current sales volume is at the rate of $4 million
 annually.
     Current product lines include:
     -- The ReBuilder(R) -- A hand-held, electronic, FDA-approved medical
        device that rebuilds nerves to stop numbness and pain, increases blood
        flow to the legs and feet which supports the nutritional needs of these
        newly awakened nerves, and increases calf muscle strength to restore
        mobility to those who suffer from Peripheral Neuropathy.
 
     -- The Phillips Molluscum Treatment System for Molluscum Contagiosum --
        The Company manufactures, markets, and sells a complete line of
        treatment products designed to address and heal Molluscum Contagiosum,
        a contagious skin infection (http://www.molluscum.com).
 
     -- Personal Hygiene products for diabetics -- The Company has developed a
        complete line of products for people who suffer from diabetes.  Soon to
        be released, this line utilizes RBRM's proprietary nano-silver based
        technology.  The product line includes mouthwash, bar soap, body wash,
        shampoo, anti-infection ointment, flexible bandages, lip balm, and
        deodorant.
 
     -- The Company is currently finalizing its research and development of an
        electronic allergy detection system and a pocket-sized electronic
        instrument to be used by nurses to make drawing blood samples simple
        and painless.
     About Dr. David B. Phillips:
     Company founder David B. Phillips, Ph.D. has been inventing,
 manufacturing, and marketing medical devices since 1975. He is most
 recognized for the GST System for Breast Cancer Detection, the Phillips
 Molluscum Treatment System, and the FirsTemp Infra-red ear thermometer (for
 which he received the Inventor of the Year Award in 1988). He holds several
 international patents.
     About Premier Media Services:
     Premier Media Services offers multi-faceted public and investor
 relations campaigns designed to maximize institutional and investor
 awareness of public companies traded on all major exchanges. Located in the
 greater Phoenix, AZ, area, Premier Media is a woman-owned and operated
 entity.
     Forward-Looking Statements:
     This release contains forward-looking statements, which are made
 pursuant to the safe harbor provisions of the Private Securities Litigation
 Reform Act of 1955. We use words such as "anticipate," "believe," "expect,"
 "future," "intend," "plan," and similar expressions to identify
 forward-looking statements. Forward-looking statements include, without
 limitation, our ability to increase income streams, to grow revenue and
 earnings, and to obtain additional patents and strategic partnerships or
 research projects. These statements are only predictions and are subject to
 certain risks, uncertainties and assumptions, which are identified and
 described in any Company public filings with the Securities and Exchange
 Commission (http://www.sec.gov).
 
 

SOURCE ReBuilder Medical Technologies, Inc.